Bloqueo de la familia ERBB: TKI’s Irreversibles vs. Reversibles - page 11

Lux Lung 7

Paz-Ares ESMO 2016

Overall Survival

Afatinib

Gefitinib

Events

109

117

Median, mo

27.9

24.5

(95% CI)

-value

0.86

(0.66-1.12)

0.2580

Median follow up 42.6 m

Median treatment duration (afatinib vs gefitinib) 13.7 vs 11.5 m

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,2,3,4,5,6,7,8,9,10 12,13,14,15,16,17,18